User:Scribologer/sandbox

MAIA Biotechnology, Inc. is a public American biotechnology company (NYSE: MAIA), headquartered in Chicago, Illinois. The company is active in the field of targeted therapy and immune-oncology with focus on the development and commercialization of novel drugs that meaningfully improve and extend the lives of people with cancer.

The company's lead product candidate, THIO, is a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

THIO (aka 6-thio-dG, 6-thio-2’-deoxyguanosine)
THIO is a direct telomere targeting agent.